Merck and genOway Form CRISPR/Cas9 Strategic Alliance to Devel...
DARMSTADT, Germany, Dec. 11, 2018 /PRNewswire-AsiaNet/ -- - genOway to acquire exclusive rights to Merck's foundationalgenome-editing patents to produce, sell rodent models- New technologies and solutions to be developed using CRISPR/Cas9to accelerate delive...
Read more https://view-release/?pr-id=76687